Brain energy metabolism and blood-brain barrier permeability in depressive patients: analyses of creatine, creatinine, urate, and albumin in CSF and blood.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Biological Psychiatry

• Publication date

  1984-08-01

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 6498242
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased vulnerability of the blood-brain barrier to acute hypertension following depletion of brain noradrenaline

  2005cited by this paper
• Simultaneous liquid-chromatographic determination of hypoxanthine, xanthine, urate, and creatinine in cerebrospinal fluid, with direct injection.

  1983cited by this paper
• Life at risk: markers of suicidality in depression.

  1983cited by this paper
• Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method.

  1983cited by this paper
• Oxypurines in cerebrospinal fluid as indices of disturbed brain metabolism. A clinical study of ischemic brain diseases.

  1983cited by this paper
• Purine and monoamine metabolites in cerebrospinal fluid: parallel purinergic and monoaminergic activation in depressive illness?

  1983cited by this paper
• Brain purinergic activity linked with depressive symptomatology: hypoxanthine and xanthine in CSF of patients with major depressive disorders.

  1983cited by this paper
• Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol.

  1983cited by this paper
• Role of the central adrenergic system in mediating amitriptyline-induced alteration in the mammalian blood-brain barrier in vivo.

  1982cited by this paper
• Purinergic regulation of food intake.

  1982cited by this paper
• Impairment of the Blood-Brain Barrier as an Aetiological Factor in Paranoid Psychosis

  1982cited by this paper
• The role of adenosine and its nucleotides in central synaptic transmission.

  1981cited by this paper
• Physiological roles for adenosine and adenosine 5'-triphosphate in the nervous system.

  1981cited by this paper
• Hamilton Depression Rating Scale. Extracted from Regular and Change Versions of the Schedule for Affective Disorders and Schizophrenia.

  1981cited by this paper
• Monoamine metabolites in successive samples of spinal fluid

  1981cited by this paper
• Modulation of neurotransmission by purine nucleotides and nucleosides.

  1980cited by this paper
• Deleterious Effect of Glucose Pretreatment on Recovery from Diffuse Cerebral Ischemia in the Cat: II. Regional Metabolite Levels

  1980cited by this paper
• Use of the Research Diagnostic Criteria and the Schedule for Affective Disorders and Schizophrenia to study affective disorders.

  1979cited by this paper
• Research diagnostic criteria: rationale and reliability.

  1978cited by this paper
• IS A FAMILIAL DEFINITION OF DEPRESSION BOTH FEASIBLE AND VALID?

  1978cited by this paper
• Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.

  1977cited by this paper
• CEREBROSPINAL URIC ACID IN ALCOHOLICS

  1973cited by this paper
• Electroimmuno assay.

  1972cited by this paper
• URIC ACID IN THE CEREBROSPINAL FLUID IN CEREBRAL ATROPHY

  1965cited by this paper
• URIC ACID IN THE CEREBROSPINAL FLUID IN PSYCHIATRIC DISORDERS

  1965cited by this paper

• Differential Regulation of Proteins Related to the Blood–Brain Barrier in Stress‐Resilient and Stress‐Susceptible Mice

  2025cites this paper
• Vascular depression: A comprehensive exploration of the definition, mechanisms, and clinical challenges.

  2025cites this paper
• Design and validation of novel brain-penetrant HCN channel inhibitors to ameliorate social stress-induced susceptible phenotype

  2025cites this paper
• Lower creatinine levels are associated with an increased risk of depression: evidence from the China Health and Retirement Longitudinal Study

  2025cites this paper
• Across Barriers: Blood–Brain and Gut Barrier Signaling in Psychiatric Disorders

  2025cites this paper
• Beyond the Surface: Tracing the Evolution of Inflammatory Mechanism in Depression through Bibliometric Analysis

  2025cites this paper
• Research progress on the correlation between biological rhythms and the blood-brain barrier after ischemic stroke

  2025cites this paper
• The role of microbiome in gut-brain-axis dysbiosis causing depression: From mechanisms to treatment.

  2025cites this paper
• Hypoxanthine Produces Rapid Antidepressant Effects by Suppressing Inflammation in Serum and Hippocampus.

  2024cites this paper
• Clinical Analysis and Detection of Creatinine by Conventional Methods and Electrochemical Biosensors: A Review

  2024cites this paper
• Unraveling the Role of the Blood-Brain Barrier in the Pathophysiology of Depression: Recent Advances and Future Perspectives

  2024cites this paper
• A Potential Role for MAGI-1 in the Bi-Directional Relationship Between Major Depressive Disorder and Cardiovascular Disease

  2024cites this paper
• Convergence of endothelial dysfunction, inflammation and glucocorticoid resistance in depression-related cardiovascular diseases

  2024cites this paper
• Breakdown of the blood-brain barrier in depressed mice induced by chronic unpredictable mild stress.

  2024cites this paper
• Exploration of Nutraceutical Potentials of Isorhapontigenin, Oxyresveratrol and Pterostilbene: A Metabolomic Approach

  2024cites this paper
• Higher Blood-brain barrier permeability in patients with major depressive disorder identified by DCE-MRI imaging.

  2023cites this paper
• Altered brain dopamine metabolism is a trait marker for bipolar disorder

  2023cites this paper
• Major Depressive Disorder, Inflammation, and Nutrition: A Tricky Pattern?

  2023cites this paper
• Glutamatergic dysfunction, neuroplasticity, and redox status in the peripheral blood of patients with motor conversion disorders (functional movement disorders): a first step towards potential biomarkers discovery

  2023cites this paper
• Barrier–environment interactions along the gut–brain axis and their influence on cognition and behaviour throughout the lifespan

  2023cites this paper
• Intertwined associations between oxytocin, immune system and major depressive disorder

  2023cites this paper
• Sickness Behaviour and Depression: An Updated Model of Peripheral-Central Immunity Interactions.

  2023cites this paper
• Beyond the neuron: Role of non-neuronal cells in stress disorders.

  2022cites this paper
• Sex differences in the blood-brain barrier: implications for mental health.

  2022cites this paper
• Immunomodulatory Role of CB2 Receptors in Emotional and Cognitive Disorders

  2022cites this paper
• Blood brain barrier and inflammation in depression.

  2022cites this paper
• Blood–Brain Barrier Dysfunction in the Pathogenesis of Major Depressive Disorder

  2021influential citation
• Highlighting Immune System and Stress in Major Depressive Disorder, Parkinson’s, and Alzheimer’s Diseases, with a Connection with Serotonin

  2021cites this paper
• TNF-Alpha as an Initiator of Allodynia and Anxiety-Like Behaviors in a Preclinical Model of PTSD and Comorbid Pain

  2021cites this paper
• Creatine in Health and Disease

  2021cites this paper
• Biogeography of the large intestinal mucosal and luminal microbiome in cynomolgus macaques with depressive-like behavior

  2021cites this paper
• Microvascular Contribution to Late-Onset Depression: Mechanisms, Current Evidence, Association With Other Brain Diseases, and Therapeutic Perspectives.

  2021influential citation
• Microglia and their LAG3 checkpoint underlie the antidepressant and neurogenesis-enhancing effects of electroconvulsive stimulation

  2021cites this paper
• Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders

  2021cites this paper
• Blood-Brain Barrier Dynamics to Maintain Brain Homeostasis.

  2021cites this paper
• Blood-brain barrier regulation in psychiatric disorders.

  2020cites this paper
• The Bidirectional Relationship of Depression and Inflammation: Double Trouble.

  2020cites this paper
• The role of inflammation and oxidative stress in depression and cardiovascular disease

  2020cites this paper
• Molecular adaptations of the blood–brain barrier promote stress resilience vs. depression

  2020cites this paper
• A reduced concentration of brain interstitial amino acids is associated with depression in subarachnoid hemorrhage patients

  2019cites this paper
• Neurobiology of Resilience: Interface Between Mind and Body.

  2019cites this paper
• The Role of Brain Barriers in Maintaining Brain Vitamin Levels.

  2019cites this paper
• Neurobiology of resilience in depression: immune and vascular insights from human and animal studies

  2019cites this paper
• Creatine for the Treatment of Depression

  2019cites this paper
• Beyond sports: Efficacy and safety of creatine supplementation in pathological or paraphysiological conditions of brain and muscle

  2019cites this paper
• Molecular, Cellular, and Circuit Basis of Depression Susceptibility and Resilience

  2019cites this paper
• Identification of a microglial activation‐dependent antidepressant effect of amphotericin B liposome

  2019cites this paper
• Central and Peripheral Inflammation Link Metabolic Syndrome and Major Depressive Disorder.

  2019cites this paper
• Resilience and immunity

  2018cites this paper
• Social stress induces neurovascular pathology promoting depression

  2017cites this paper
• Quantitative proteomic study of the plasma reveals acute phase response and LXR/RXR and FXR/RXR activation in the chronic unpredictable mild stress mouse model of depression

  2017cites this paper
• iTRAQ technology-based identification of human peripheral serum proteins associated with depression.

  2016cites this paper
• Dopamine: Receptors, Functions, Synthesis, Pathways, Locations andMental Disorders: Review of Literatures

  2016cites this paper
• Interactions between Stress-induced Inflammation, Glycogen Synthase Kinase 3 (GSK3), and Depression

  2016cites this paper
• Evidence of cerebrospinal fluid abnormalities in patients with depressive syndromes.

  2016cites this paper
• Changes to Intermediary Metabolites in Sporadic and LRRK2 Parkinson's Disease Demonstrated by Proton Magnetic Resonance Spectroscopy

  2015cites this paper
• The Aqueous Extract of Ziziphora persica Cause Positive Mood on Depressive Rat

  2014cites this paper
• Blood Levels of S-100 Calcium-Binding Protein B, High-Sensitivity C-Reactive Protein, and Interleukin-6 for Changes in Depressive Symptom Severity after Coronary Artery Bypass Grafting: Prospective Cohort Nested within a Randomized, Controlled Trial

  2014cites this paper
• Evaluation of blood-brain barrier permeability in tryptophan hydroxylase 2-knockout mice

  2014cites this paper
• The Correlation between Uric Acid Levels and Amyotrophic Lateral Sclerosis

  2013cites this paper
• Serum Urate and the Risk of Parkinson's Disease: Results From a Meta-Analysis

  2013cites this paper
• Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence

  2013cites this paper
• Significantly lower levels of hypoxanthine and creatinine in the CSF of patients with schizophrenia

  2013cites this paper
• The role of glycogen and lactate in supporting action potential conduction in mouse central white matter and peripheral nerve

  2012cites this paper
• Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats.

  2012cites this paper
• Comparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulation.

  2012cites this paper
• Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?

  2012cites this paper
• Lower serum UA levels in Parkinson's disease patients in the Chinese population.

  2012cites this paper
• Creatine, Brain Functioning, and Behavior

  2011cites this paper
• A Potential Role for Creatine in Drug Abuse?

  2011cites this paper
• CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's disease.

  2011cites this paper
• Chronic Creatine Supplementation Alters Depression-like Behavior in Rodents in a Sex-Dependent Manner

  2010cites this paper
• Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis.

  2010cites this paper
• Changements dans le circuit de la récompense suite à la bulbectomie olfactive : une nouvelle approche pour étudier des antidépresseurs

  2009cites this paper
• Urate as a predictor of the rate of clinical decline in Parkinson disease.

  2009cites this paper
• TITLE: Caffeine, Adenosine Receptors and Estrogen in Toxin Models of Parkinson’s Disease

  2008cites this paper
• Uric acid in Parkinson's disease

  2008cites this paper
• Plasma urate and risk of Parkinson's disease.

  2007cites this paper
• Award Number: W81XWH-04-1-0881 TITLE: Caffeine, Adenosine Receptors and Estrogen in Toxin Models of Parkinson’s Disease

  2006cites this paper
• Creatinine and creatine in CSF: indices of brain energy metabolism in depression

  2005cites this paper
• A neuropsychotoxicological assessment of workers in a sodium azide production plant

  2003cites this paper
• Both aging and chronic fluoxetine increase S100B content in the mouse hippocampus

  2003cites this paper
• Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate.

  2003cites this paper
• Creatine and creatinine metabolism.

  2000cites this paper
• Increased cerebrospinal fluid glutamine levels in depressed patients.

  2000cites this paper
• Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders.

  2000cites this paper
• Proton magnetic resonance spectroscopy of cerebrospinal fluid in neurodegenerative disease: Indication of glial energy impairment in Huntington chorea, but not Parkinson disease

  2000cites this paper
• Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder

  1999cites this paper
• Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio.

  1998cites this paper
• Guanidino compound levels in brain regions of non-dialyzed uremic patients.

  1995cites this paper
• Effect of adenosine and its metabolites on the hypothalamo-pituitary-adrenal axis

  1995cites this paper
• The effect of age on concentrations of monoamines, amino acids, and their related substances in the cerebrospinal fluid

  1993cites this paper
• Substance P and neuropsychiatric disorders: an overview.

  1992cites this paper
• Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy.

  1992cites this paper
• Cerebrospinal fluid calcium, parathyroid hormone, and monoamine and purine metabolites and the blood-brain barrier function in primary hyperparathyroidism.

  1991cites this paper
• Prednisone effects on blood-brain barrier permeability and CNS IgG synthesis in healthy humans.

  1990cites this paper
• Determination of N‐Acetylaspartic Acid in Human Cerebrospinal Fluid by Gas Chromatography–Mass Spectrometry

  1990cites this paper
• CSF creatinine in schizophrenia.

  1988cites this paper
• Hypoxanthine, xanthine, urate and creatinine concentration gradients in cerebrospinal fluid.

  1988cites this paper
• Purine metabolites in the CSF in presenile and senile dementia of Alzheimer type, and in multi infarct dementia.

  1988cites this paper